Granulosa cell-specific inactivation of follistatin causes female fertility defects

Molecular Endocrinology

Volumn 18, Issue 4, 2004, Pages 953-967

  Jorgez, Carolina J ^a   Klysik, Michal ^a   Jamin, Soazik P ^a   Behringer, Richard R ^a   Matzuk, Martin M ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; FOLLISTATIN; FOLLITROPIN; LUTEINIZING HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SPECIFICITY; FEMALE; FEMALE FERTILITY; GRANULOSA CELL; HORMONAL REGULATION; INFERTILITY; MOUSE; NONHUMAN; OVARY FOLLICLE; OVARY INSUFFICIENCY; PATHOGENESIS; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; FEMALE; FOLLISTATIN; GRANULOSA CELLS; INFERTILITY, FEMALE; INTEGRASES; MICE; MICE, TRANSGENIC; OVARY;

ANIMALIA; MUS MUSCULUS;

EID: 1842426431     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0301     Document Type: Article

References (63)

1. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R 1987 Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 84:8282-8286
2. Esch FS, Shimasaki S, Mercado M, Cooksey K, Ung N, Ying S, Ueno N, Guillemin R 1987 Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Mol Endocrinol 1:849-855
3. Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying SY, Ung N, Guillemin R 1988 Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA 85: 4218-4222
4. Nakamura T, Taklo K, Eto Y, Shibai H, Titani K, Sugino H 1990 Activin-binding protein from rat ovary is follistatin. Science 247:836-838
5. Welt C, Sidis Y, Keutmann H, Schneyer A 2002 Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 227:724-752
6. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J 1986 Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321:776-779
7. Schneyer AL, Rzucidlo DA, Sluss PM, Crowley Jr WF 1994 Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 135:667-674
8. Shimonaka M, Inouye S, Shimasaki S, Ling N 1991 Follistatin binds to both activin and inhibin through the common subunit. Endocrinology 128:3313-3315
9. Fainsod A, DeiBler K, Yelin R, Marom K, Epstein M, Pillemer G, Steinbeisser H, Blum M 1997 The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4. Mech Dev 63:39-50
10. Iemura S, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N 1998 Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 95:9337-9342
11. Gamer LW, Wolfman NM, Celeste AJ, Hattersley G, Hewick R, Rosen V 1999 A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev Biol 208:222-232
12. Otsuka F, Moore RK, Iemura S, Ueno N, Shimasaki S 2001 Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Blophys Res Commun 289:961-966
13. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM 1999 Molecular characterization of the follicle defects in the growth differentiation factor-9-deficient ovary. Mol Endocrinol 13:1018-1034
14. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S-I, Ueno N, Sampath K, Chang RJ, Erickson GF 1999 A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA 96:7282-7287
15. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM 1998 The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12: 1809-1817
16. Matzuk MM, Lu H, Vogel H, Sellheyer K, Roop DR, Bradley A 1995 Multiple defects and perinatal death in mice deficient in follistatin. Nature 372:360-363
17. Guo Q, Kumar TR, Woodruff T, Hadsell LA, DeMayo FJ, Matzuk MM 1998 Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol 12:96-106
18. Shimasaki S, Koga M, Buscaglia ML, Simmons DM, Bicsak TA, Ling N 1989 Follistatin gene expression in the ovary and extragonadal tissues. Mol Endocrinol 3: 651-659
19. Michel U, Albiston A, Findlay JK 1990 Rat follistatin: gonadal and extragonadal expression and evidence for alternative splicing. Biochem Biophys Res Commun 173: 401-407
20. Lakso M, Pichel JG, German JR, Sauer B, Okamoto Y, Lee E, Alt FW, Westphal H 1996 Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci USA 93:5860-5865
21. di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, Picard JY, Vigier B, Josso N, Cate R 1994 Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol Endocrinol 8:1006-1020
22. Baarends WM, van Helmond MJ, Post M, van der Schoot PJ, Hoogerbrugge JW, de Winter JP, Uilenbroeck JT, Karels B, Wilming LG, Meijers JH, Themmen APN, Grootegoed JA 1994 A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Mullerian duct. Development 120:189-197
23. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, Grootegoed JA 1995 Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136:4951-4962
24. Teixeira J, He WW, Shah PC, Morikawa N, Lee MM, Catlin EA, Hudson PL, Wing J, MacLaughlin DT, Donahoe PK 1996 Developmental expression of a candidate Mullerian inhibiting substance type II receptor. Endocrinology 137:160-165
25. Racine C, Rey R, Forest MG, Louis F, Ferre A, Huhtaniemi I, Josso N, di Clemente N 1998 Receptors for anti-mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA 95:594-599
26. Mishina Y 2001 The in vivo function of Mullerian-inhibiting substance during mammalian sexual development. In: Matzuk MM, Brown CW, Kumar TR, eds. Contemporary endocrinology: transgenics in endocrinology. Totowa, NJ: Humana Press Inc; 41-59
27. Teixeira J, Maheswaran S, Donahoe PK 2001 Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 22:657-674
28. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR 2002 Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 32:408-410
29. Soriano P 1999 Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71
30. Yan C, Wang P, DeMayo J, DeMayo F, Elvin J, Carino C, Prasad S, Skinner S, Dunbar B, Dube J, Celeste A, Matzuk M 2001 Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 15:854-866
31. Matzuk MM, Finegold MJ, Su J-GJ, Hsueh AJW, Bradley A 1992 α-Inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 360:313-319
32. Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, Finegold MJ 1996 Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res 51:123-157
33. Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byme MC, Matzuk MM 1999 Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Mol Endocrinol 13:851-865
34. Couse JF, Hewitt SC, Bunch DO, Sar M, Walker VR, Davis BJ, Korach KS 1999 Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β. Science 286:2328-2331
35. Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL 1990 Abnormal sexual development in transgenic mice chronically expressing Müllerian-inhibiting substance. Nature 345:167-170
36. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM 1996 Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383: 531-535
37. Meinhardt A, O'Bryan MK, McFarlane JR, Loveland KL, Mallidis C, Foulds LM, Phillips DJ, de Kretser DM 1998 Localization of follistatin in the rat testis. J Reprod Fertil 112:233-241
38. Hartmann BW, Kirchengast S, Albrecht A, Laml T, Soregi G, Huber JC 1997 Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecol Obstet Invest 44:127-131
39. Matzuk MM, Kumar TR, Bradley A 1995 Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374:356-360
40. Kawakami S, Fujii Y, Winters SJ 2001 Follistatin production by skin fibroblasts and its regulation by dexamethasone. Mol Cell Endocrinol 172:157-167
41. Nakamura K, Matzuk MM, Gerstmayer B, Bosio A, Lauster R, Miyachi Y, Werner S, Paus R 2003 Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin. FASEB J 17: 497-499
42. Jhaveri S, Erzurumlu RS, Chiaia N, Kumar TR, Matzuk MM 1998 Defective whisker follicles and altered brain-stem patterns in activin and follistatin knockout mice. Mol Cell Neurosci 12:206-219
43. Roberts VJ, Bentley CA, Guo Q, Matzuk MM, Woodruff TK 1996 Tissue-specific binding of radiolabeled activin A by activin receptors and follistatin in postimplantation rat and mouse embryos. Endocrinology 137:4201-4209
44. Kojima I, Maeshima A, Zhang YQ 2001 Role of the activin-follistatin system in the morphogenesis and regeneration of the renal tubules. Mol Cell Endocrinol 180: 179-182
45. Funaba M, Ogawa K, Murata T, Fujimura H, Murata E, Abe M, Takahashi M, Torii K 1996 Follistatin and activin in bone: expression and localization during endochondral bone development. Endocrinology 137: 4250-4259
46. Kwan KM 2002 Conditional alleles in mice: practical considerations for tissue-specific knockouts. Genesis 32:49-62
47. Conway GS 2000 Premature ovarian failure. Br Med Bull 56:643-649
48. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, Shawker TH, Merino MJ 1994 Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 79:1470-1475
49. Kalantaridou SN, Nelson LM 2000 Premature ovarian failure is not premature menopause. Ann NY Acad Sci 900:393-402
50. Mazer NA 2002 Testosterone deficiency in women: etiologies, diagnosis, and emerging treatments. Int J Fertil Womens Med 47:77-86
51. Doldi N, Belvisi L, Bassan M, Fusi FM, Ferrari A 1998 Premature ovarian failure: steroid synthesis and autoimmunity. Gynecol Endocrinol 12:23-28
52. Falsetti L, Scalchi S, Villani MT, Bugari G 1999 Premature ovarian failure. Gynecol Endocrinol 13:189-195
53. Johnson Jr TR, Peterson EP 1979 Gonadotropin-induced pregnancy following "premature ovarian failure." Fertil Steril 31:351-352
54. Nelson LM, Kimzey LM, White BJ, Merriam GR 1992 Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril 57:50-55
55. van Kasteren YM, Hoek A, Schoemaker J 1995 Ovulation induction in premature ovarian failure: a placebocontrolled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertil Steril 64:273-278
56. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss III JF, Spielman RS, Dunaif A 1999 Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 96:8573-8578
57. Urbanek M, Wu X, Vickery KR, Kao LC, Christenson LK, Schneyer A, Legro RS, Driscoll DA, Strauss III JF, Dunaif A, Spielman RS 2000 Allelic variants of the follistatin gene in polycystic ovary syndrome. J Clin Endocrinol Metab 85:4455-4461
58. Liao WX, Roy AC, Ng SC 2000 Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome. Mol Hum Reprod 6:587-590
59. Calvo RM, Villuendas G, Sancho J, San Millan JL, Escobar-Morreale HF 2001 Role of the follistatin gene in women with polycystic ovary syndrome. Fertil Steril 75:1020-1023
60. Nishihara T, Okahashi N, Ueda N 1993 Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197:985-991
61. Choi KC, Kang SK, Tai CJ, Auersperg N, Leung PC 2001 The regulation of apoptosis by activin and transforming growth factor-β in early neoplastic and tumorigenic ovarian surface epithelium. J Clin Endocrinol Metab 86:2125-2135
62. Woodruff TK, Lyon RJ, Hansen SE, Rice GC, Mather JP 1990 Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology 127:3196-3205
63. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM 1999 Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 13: 1035-1048